前列腺癌的超声波分子成像通过PSMA向的生物合成GVs
Kezhi Yu1,2,3, Yuanyuan Wang2, Zihang Wang4
1Department of Ultrasound, Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, 519000, Guangdong, P. R. China. huangyq39@mail.sysu.edu.cn.
Biomaterials science
|December 2, 2025
概括
研究人员开发了针对前列腺特异性膜抗原 (PSMA) 的新型气囊 (GVs),用于增强超声波成像. 这些PSMA-GV对前列腺癌细胞具有很高的特异性,可以通过改进的分子成像信号更早,更准确地进行诊断.
科学领域:
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
- 分子成像学分子成像学
背景情况:
- 早期诊断前列腺癌至关重要,但受到当前方法的敏感性,成本和辐射风险的限制.
- 前列腺特异性膜抗原 (PSMA) 在前列腺癌中高度表达,使其成为关键的诊断标.
- 开发有针对性的对比剂可以显著改善早期癌症检测.
研究的目的:
- 使用针对PSMA的纳米体修饰气囊 (GVs) 创建一种新的超声波对比剂.
- 评估这些PSMA向GVs (PSMA-GVs) 早期前列腺癌诊断的疗效和特异性.
- 评估PSMA-GVs的生物相容性和体内性能.
主要方法:
- 气体囊泡 (GVs) 被提取并使用针对PSMA的纳米体 (Nb-PSMA) 进行修改.
- 在PC-3细胞上使用流细胞计和共聚焦显微镜对PSMA-GV进行了大小和特异性的特征.
- 在前列腺癌小鼠模型上进行了体内对比增强超声波成像,并进行了生物相容性评估.
主要成果:
- PSMA-GVs表现出与PSMA阳性PC-3细胞的特定结合,并表现出均的大小 (267.73 ± 2.86 nm).
- 在体内成像显示,与控制GV相比,PSMA-GV的瘤信号减弱显著较慢.
- PSMA-GVs显示了增强的瘤向,更强大和更持久的分子成像信号,以及良好的生物相容性.
结论:
- 针对PSMA的纳米体修饰气囊为前列腺癌的早期超声波分子成像提供了一个有希望的新策略.
- 这种方法通过提供特定的,高对比度的分子成像信号来提高诊断准确性.
- 开发的PSMA-GVs表现出良好的生物相容性和优越的性能,与传统的药物相比.
相关概念视频
01:29Positron Emission Tomography
6.2K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.2K
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
853
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
853